Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCardia, Inc.BCDA · Entity 7752 | Director · President and CEO | September 29, 2026 | October 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCardia, Inc.
Report date September 29, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 384,885 |
Reported balance
After 2026-09-29 transaction · row 1
1 source rowRow 1 · 2026-09-29 · Purchase · Acquired 1,000 · Balance 384,885 F1: This transaction was executed in multiple trades ranging from $1.02 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades ranging from $1.02 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2019 Filed Jun 6, 2019 00:23 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,900 | $1.01 | $1,919.00 |
DisclosureSEC source: 0001437749-19-011512 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 745,042 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.005 to $1.015 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:01 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 200 | $1.28 | $256.00 |
DisclosureSEC source: 0001437749-19-011064 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 743,142 Read SEC document |
| May 17, 2019 Filed May 21, 2019 00:14 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,100 | $1.18 | $1,293.60 |
DisclosureSEC source: 0001437749-19-010527 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 742,942 F2 · price: This transaction was executed in multiple trades at prices ranging from $1.15 to $1.20 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 16, 2019 Filed May 21, 2019 00:14 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,000 | $1.13 | $1,128.00 |
DisclosureSEC source: 0001437749-19-010527 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 741,842 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.085 to $1.17 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 01, 2019 Filed May 2, 2019 21:03 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 6,000 | $0.99 | $5,952.00 |
DisclosureSEC source: 0001437749-19-008608 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 740,842 F2 · price: This transaction was executed in multiple trades at prices ranging from $0.98 to $1.06 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 30, 2019 Filed May 2, 2019 21:03 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,000 | $1.19 | $5,960.00 |
DisclosureSEC source: 0001437749-19-008608 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 734,842 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.13 to $1.23 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 13, 2019 Filed Feb 16, 2019 02:18 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 50 | $1.59 | $79.50 |
DisclosureSEC source: 0001437749-19-002788 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 729,842 Read SEC document |
| November 16, 2018 Filed Nov 17, 2018 01:23 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,400 | $2.39 | $3,352.44 |
DisclosureSEC source: 0001437749-18-021034 · rdgdoc.xml · nonDerivative · entry 3 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 729,792 F3 · price: This transaction was executed in multiple trades at prices ranging from $2.325 to $2.40 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 15, 2018 Filed Nov 17, 2018 01:23 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 2,500 | $2.43 | $6,071.50 |
DisclosureSEC source: 0001437749-18-021034 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 728,392 F2 · price: This transaction was executed in multiple trades at prices ranging from $2.355 to $2.45 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 14, 2018 Filed Nov 17, 2018 01:23 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 2,500 | $2.22 | $5,560.00 |
DisclosureSEC source: 0001437749-18-021034 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 725,892 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.05 to $2.50 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 13, 2018 Filed Nov 14, 2018 01:12 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 2,800 | $2.08 | $5,826.80 |
DisclosureSEC source: 0001437749-18-020647 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 723,392 F2 · price: This transaction was executed in multiple trades at prices ranging from $2.05 to $2.10 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 01:12 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,100 | $2.35 | $2,585.00 |
DisclosureSEC source: 0001437749-18-020647 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720,592 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.30 to $2.39 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 09, 2018 Filed Nov 9, 2018 22:42 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 400 | $2.50 | $1,000.00 |
DisclosureSEC source: 0001437749-18-020341 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 719,492 Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 22:42 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 100 | $2.51 | $251.00 |
DisclosureSEC source: 0001437749-18-020341 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 719,092 Read SEC document |
| November 02, 2018 Filed Nov 7, 2018 02:40 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 400 | $2.52 | $1,008.00 |
DisclosureSEC source: 0001437749-18-019720 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 718,992 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.44 to $2.60 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| October 30, 2018 Filed Nov 2, 2018 00:28 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 300 | $2.55 | $765.00 |
DisclosureSEC source: 0001437749-18-019336 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 718,592 Read SEC document |
| October 26, 2018 Filed Oct 29, 2018 22:31 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 3,250 | $2.32 | $7,549.75 |
DisclosureSEC source: 0001437749-18-018983 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 718,292 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.24 to $2.55 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| October 25, 2018 Filed Oct 29, 2018 22:31 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 600 | $2.55 | $1,530.00 |
DisclosureSEC source: 0001437749-18-018983 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 715,042 Read SEC document |
| September 20, 2018 Filed Sep 25, 2018 01:40 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 800 | $1.82 | $1,458.40 |
DisclosureSEC source: 0001437749-18-017390 · rdgdoc.xml · nonDerivative · entry 3 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714,442 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.71 to $1.99 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 19, 2018 Filed Sep 20, 2018 23:44 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 500 | $1.71 | $854.00 |
DisclosureSEC source: 0001437749-18-017268 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713,342 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.70 to $1.72 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 18, 2018 Filed Sep 18, 2018 23:49 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 200 | $1.65 | $330.00 |
DisclosureSEC source: 0001437749-18-017180 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 712,642 F2 · price: This transaction was executed in multiple trades at prices ranging from $1.60 to $1.70 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 18, 2018 Filed Sep 20, 2018 23:44 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 200 | $1.50 | $300.00 |
DisclosureSEC source: 0001437749-18-017268 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 712,842 Read SEC document |
| September 17, 2018 Filed Sep 25, 2018 01:40 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 200 | $1.58 | $316.00 |
DisclosureSEC source: 0001437749-18-017390 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713,642 Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 23:49 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 500 | $1.56 | $780.00 |
DisclosureSEC source: 0001437749-18-017180 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 712,442 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.54 to $1.58 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 12, 2018 Filed Sep 12, 2018 23:27 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 800 | $1.45 | $1,160.00 |
DisclosureSEC source: 0001437749-18-016939 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 711,942 F2 · price: This transaction was executed in multiple trades at prices ranging from $1.395 to $1.55 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 12, 2018 Filed Sep 25, 2018 01:40 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 100 | $1.40 | $140.00 |
DisclosureSEC source: 0001437749-18-017390 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713,442 Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 23:27 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 800 | $1.28 | $1,024.00 |
DisclosureSEC source: 0001437749-18-016939 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 711,142 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.20 to $1.44 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 05, 2018 Filed Sep 5, 2018 23:25 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,000 | $1.33 | $6,650.00 |
DisclosureSEC source: 0001437749-18-016637 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 710,342 Read SEC document |
| August 27, 2018 Filed Aug 28, 2018 21:47 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,500 | $1.46 | $2,190.00 |
DisclosureSEC source: 0001437749-18-016261 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705,342 Read SEC document |
| June 11, 2018 Filed Jun 12, 2018 00:33 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 3,000 | $1.45 | $4,350.00 |
DisclosureSEC source: 0001437749-18-011581 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703,842 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.44 to $1.45, the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the Registrant, or a security holder of the Registrant. Read SEC document |
| April 18, 2018 Filed Apr 20, 2018 22:58 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,000 | $1.45 | $1,450.00 |
DisclosureSEC source: 0001437749-18-007382 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700,842 Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 18:25 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,000 | $2.03 | $10,150.00 |
DisclosureSEC source: 0001437749-18-005235 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 699,842 Read SEC document |
| February 01, 2018 Filed Mar 22, 2018 18:24 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001437749-18-005233 · rdgdoc.xml · derivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common stock · 400,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 1/48th of the shares on March 1, 2018 and each monthly anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.